Carbidopa and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carbidopa (carbidopa) and Abilify (aripiprazole). Common drug interactions include fatigue among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Carbidopa and Abilify. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Carbidopa?

Carbidopa has active ingredients of carbidopa. It is often used in parkinson's disease. eHealthMe is studying from 3,061 Carbidopa users. Check the latest studies of Carbidopa.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.



On Aug, 03, 2026

19 people who take Carbidopa and Abilify together, and have interactions are studied.

Carbidopa and Abilify drug interactions.

What are the common drug interactions of Carbidopa and Abilify, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Insomnia (sleeplessness)
  3. Urinary tract infection
  4. Anxiety
  5. Chronic kidney disease
  6. Compulsive shopping
  7. Dehydration (dryness resulting from the removal of water)
  8. Fall
  9. Gait disturbance
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Balance disorder
  3. Herpes zoster
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Visual impairment
  6. General physical health deterioration (weak health status)
  7. Lumbar puncture
  8. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  9. Streptococcal infection

What are the common drug interactions of Carbidopa and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dysphagia (a condition in which swallowing is difficult or painful)

50-59:

  1. Jaw disorder (jaw disease)

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Balance disorder
  3. Hot flush (sudden feelings of heat)
  4. Lumbar puncture
  5. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  6. Urinary tract infection
  7. Herpes zoster
  8. Chronic kidney disease
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 10.53%
  3. Pain: 2 people, 10.53%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 10.53%
  5. Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 2 people, 10.53%
  6. Infection: 2 people, 10.53%
  7. High Blood Cholesterol: 2 people, 10.53%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
  9. Drowsiness: 2 people, 10.53%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Carbidopa and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carbidopa and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbidopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbidopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carbidopa and aripiprazole (the active ingredients of Carbidopa and Abilify, respectively), and Carbidopa and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: